Patents
Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632)
06/2002
06/27/2002US20020081645 Coding or classification of prion sample; obtain sample, monitor physical properties of sample, compare to control
06/27/2002US20020081643 Regulation of apoptosis and in vitro model for studies thereof
06/27/2002US20020081642 Serodiagnostic test; for use in the detection of microorganisms in sample
06/27/2002US20020081641 Detection of tissue modelling defects; obtain tissue sample, monitor sample for preferential enzymatic complex, compare pattern of enzyme activity with control
06/27/2002US20020081640 Method of diagnosing, monitoring, staging, imaging and treating colon cancer
06/27/2002US20020081639 Detecting cell proliferation modulator; obtain cell sample, incubate with modulator, monitor cells for adjustments in cell proliferation activity
06/27/2002US20020081638 Method for identifying compounds altering higher-order chromatin-dependent chromosome stability
06/27/2002US20020081637 Screening mammalian sample for cancer cells; obtain tissue sample, monitor sample for the expression of endothelial growth factor, the presence of enothelial growth factor exression is indicative of cancer
06/27/2002US20020081633 Methods for using 22045, a human cyclic nucleotide phosphodiesterase
06/27/2002US20020081632 Detecting cell surface receptor antagonists, agonists or ligands; obtain cells, incubate with modulator, expose to electrophoretic gel, visualize banding pattern, compare to control
06/27/2002US20020081630 Compound for use in the deteCtion of viral infectionS
06/27/2002US20020081629 Screening sample for preferentiaL particles; generate solid suppot, expose sample to support, monitor particles associations
06/27/2002US20020081628 Methods for diagnosing pervasive development disorders, dysautonomia and other neurological conditions
06/27/2002US20020081627 Inhibition of adenovirus replication by product R, A peptide nucleic acid immunomodulator
06/27/2002US20020081626 Monitoring the concentration of arginine in sample; obtain sample, incubate with binding particle, determine arginine concentration in sample
06/27/2002US20020081624 Detection of patients at risk for developing integrin antagonist/ agonist mediated disease states
06/27/2002US20020081623 Chemotactic cytokine
06/27/2002US20020081621 Detecting preferential ligand in sample; obtain target in sample, incubate with reactive support, detect bound particles
06/27/2002US20020081617 Apparatus which detects preferential particles in solution by monitoring fluorescent resonance energy transfer
06/27/2002US20020081614 Functional genomics using zinc finger proteins
06/27/2002US20020081613 Detecting cancer in a tissue sample; obtain tissue sample, screen for preferential marker, presence of marker indicates cancer
06/27/2002US20020081609 Compositions and methods for the therapy and diagnosis of breast cancer
06/27/2002US20020081608 Nucleotide sequence coding preferential polypeptide for use in the treatment and prevention of cancer
06/27/2002US20020081607 Four disulfide core domain-containing (FDCD) polynucleotides, polypeptides, and antibodies
06/27/2002US20020081605 Method for detecting growth hormone variations in humans, the variations and their uses
06/27/2002US20020081601 Methods and compositions for diagnosis and treatment of cancer based on the transcription factor ets2
06/27/2002US20020081597 Compositions and methods for detecting and quantifying gene expression
06/27/2002US20020081596 Compositions and methods for the identification, assessment, prevention, and therapy of human cancers
06/27/2002US20020081594 Screening compounds ability to induce uracil into deoxyribonucleic acid; obtain cells, expose to modulator, monitor cell metabolism, monitor cells for presence of uracil in deoxyribonucleic acids
06/27/2002US20020081589 Gene expression monitoring using universal arrays
06/27/2002US20020081588 Biosensor for use in the detection of perferential compounds in sample; for use tool in human therapeutics
06/27/2002US20020081587 Biological microbalance array module chip
06/27/2002US20020081585 Compounds for detection an inflammatory bowel disease
06/27/2002US20020081582 Making multimers such as DNA or peptides in chemical reactor by solution-based photochemical reactions involving reagents generated in situ by irradiation
06/27/2002US20020081580 Compounds for immunodiagnosis of prostate cancer and methods for their use
06/27/2002US20020081578 Nucleotide sequences coding preferential polypeptide for as anticarcinogenic agents
06/27/2002US20020081576 Antibodies directed against binding-associated epitopes
06/27/2002US20020081575 Classifiying infectious agents in sample; obtain sample for nose secretion, monitor hydrogen ion concentration, preferential hydrogen ion concentrations indicate infectious agent
06/27/2002US20020081574 Enzymatic polypeptide for use in the diagnosis, prevention and treatment of viral disease
06/27/2002US20020081573 Kit for detecting a respiratory syncytial virus in sample
06/27/2002US20020081572 Detecting modulator of viral enzymatic activity; otain three dimensional structure of enzyme, determine binding position, test modulator of enzyme activity in presence of substrate, monitor for decreased enzymatic activity
06/27/2002US20020081571 Determining activity of the glucose transporter by measuring an amount of the glucose compound transported; for screening antiretroviral protease inhibitor for metabolic side effect on glucose transport
06/27/2002US20020081570 System to detect protein-protein interactions
06/27/2002US20020081569 Screening fluid sample for preferential particles; obtain fluid sample, insert into sedimentation container, centrifuge, detect particles bound to solid phase
06/27/2002US20020081317 Bacteria rendered non-pathogenic having altered DNA adenine methylase activity, genetically engineered to express a heterologous antigen such as immunogenic antigen of a virus, protozoa, parasite or fungi
06/27/2002US20020081312 For the diagnosis and immunization of humans and animals against gastrointestinal disorders
06/27/2002US20020081310 Apoptosis-related compounds and their use
06/27/2002US20020081295 Virus-like particles for the induction of autoantibodies
06/27/2002US20020081290 Protein kinase homologs
06/27/2002US20020081263 Methods for decreasing beta amyloid protein
06/27/2002US20020081233 System for automatically testing a fluid specimen
06/27/2002US20020081232 Plurality of chemically-sensitive resistors capable of interacting with the molecule of interest to provide a resistance fingerprint that can be associated with a library of similar molecules to determine the molecule's activity
06/27/2002US20020081231 To determine Na ion level within fuel oil
06/27/2002US20020081014 Identification of objects of interest using multiple illumination schemes and finding overlap of features in corresponding multiple images
06/27/2002US20020081012 Image analyzing method and apparatus
06/27/2002US20020080849 Heat release rate calorimeter for milligram samples
06/27/2002US20020080341 Flow cytometer
06/27/2002US20020079476 Applications and devices based on nanostructured non-stoichiometric substances
06/27/2002US20020079264 Filtering device
06/27/2002US20020079236 Liquid-impermeable membrane located between a working electrode and a reference electrode and permeable to an ion that forms a chemical compound with the sulfur compounds in the liquid
06/27/2002US20020079225 Electrolyte solution for particle measuring apparatus, and particle measuring method using same
06/27/2002US20020078771 Chemical or biological attack detection and mitigation system
06/27/2002US20020078768 Apparatus and method for extracting a sample from a strip of material
06/27/2002DE19941447C2 Verfahren zur indirekten Bestimmung des Blutgerinnungsstatus Method for the indirect determination of coagulation
06/27/2002DE10064891A1 Method for documentation of optical quality control of wood bodies in which a body, such as a tree trunk, is optically measured and imaged using a digital camera array, to provide documentation for pricing and documentation
06/27/2002DE10064827A1 Sandwich assay for detecting analyte, useful e.g. for hormones, with detection or correction of the hook effect by measuring detection signals twice
06/27/2002DE10064177A1 Measuring cell with rotational symmetrical shape, used for thermal analysis of liquids e.g. milk, comprising hollow chamber for receiving liquid sample and for heating sample to prescribed temperature
06/27/2002DE10063487A1 Verfahren zur Anpassung von Aromamischungen A method for the adaptation of flavor mixtures
06/27/2002DE10061881A1 Apparatus for determination and display of alcohol content of breath allows highest occurring alcohol concentration to be measured, stored and displayed in several sections of display, independently of concentration
06/27/2002DE10061200A1 Diagnosis kit for the detection of prion-protein, for the diagnosis of infection Spongiform Encephalopathies, has a micro-particle with an antibody and a second antibody specific to a native prion-protein with a flow cytometer
06/27/2002DE10060586A1 Device for testing particle contamination of clean room lining comprises drum for receiving samples for testing connected to control unit
06/27/2002DE10058904A1 Process for detecting soil contamination by organic liquid phases in old industrial sites comprises removing air from the ground zone at the site and determining the radon concentration
06/27/2002DE10050836A1 Method for evaluating market value of pig carcass comprising determining total weight, weight and meat content of specific cuts using video technology to determine position of bones, shape of hide and fat content
06/27/2002CA2789252A1 Streptococcus pyogenes antigens and corresponding dna fragments
06/27/2002CA2714357A1 Mutations in neuronal gene sodium-channel alpha1-subunit and their polypeptides and their treatment of generalised epilepsy with febrile seizures plus
06/27/2002CA2696903A1 Roll defect management process
06/27/2002CA2439509A1 Equine ige-allotype
06/27/2002CA2433436A1 Gene expression profiles associated with osteoblast differentiation
06/27/2002CA2433308A1 Compositions and methods involving an essential staphylococcus aureus gene and its encoded protein staau_r4
06/27/2002CA2433027A1 Nucleic acid-associated proteins
06/27/2002CA2432992A1 Fab i and inhibition of apicomplexan parasites
06/27/2002CA2432924A1 Sea-trosy and related methods
06/27/2002CA2432762A1 Isolated human protease proteins, nucleic acid molecules encoding human protease proteins, and uses thereof
06/27/2002CA2432760A1 Isolated human dehydrogenases, nucleic acid molecules encoding them, and uses thereof
06/27/2002CA2432698A1 Devices for conducting binding assays
06/27/2002CA2432682A1 Methods for diagnosing and treating pediatric neoplasms
06/27/2002CA2432535A1 Device for measuring blood coagulation and method thereof
06/27/2002CA2432452A1 Analyte measurement
06/27/2002CA2432398A1 Absorbance multiplex technology
06/27/2002CA2432257A1 Treatment of bone disorders by modulation of fgfr3
06/27/2002CA2432104A1 Method and apparatus for processing an image of a tissue sample microarray
06/27/2002CA2432047A1 Immunogenic glycopeptides, screening, preparation and uses
06/27/2002CA2432036A1 Means for the diagnosis and therapy of ctcl
06/27/2002CA2431990A1 Method for modulating the binding activity of a novel icam-3 binding receptor on sinusoidal endothelial cells in liver and lymph nodes
06/27/2002CA2431935A1 Tissue treatment
06/27/2002CA2431926A1 Preparation of fluid samples by applying pressure
06/27/2002CA2431891A1 Mutations in neuronal gene sodium-channel alpha 1-subunit and their polypeptides and their treatment of generalised epilepsy with febrile seizures plus
06/27/2002CA2431884A1 Neocentromere-based mini-chromosomes or artificial chromosomes
06/27/2002CA2431882A1 Method for detecting whether an organism is homozygous or heterozygous using labelled primers and rflp
06/27/2002CA2431820A1 Replication assay for detecting anti-viral substances